Terms ending in 2030
Every in-force patent on Drexel University's record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 7,929,937 | System and Method for Blind Estimation of Multiple Carrier Frequency Offsets and Separation of User Signals in Wireless Communications Systems In force · High confidence | The Trustees of Princeton University and Drexel University | In force | High confidence | |
| US 9,359,603 | Modulation of Pre-Mrna Using Splice Modulating Oligonucleotides as Therapeutic Agents in the Treatment of Disease In force · Medium confidence | Drexel University | In force | Medium confidence | |
| US 9,885,049 | Modulation of Pre-Mrna Using Splice Modulating Oligonucleotides as Therapeutic Agents in the Treatment of Disease In force · Medium confidence | Drexel University | In force | Medium confidence | |
| US 10,041,075 | Modulation of Pre-Mrna Using Splice Modulating Oligonucleotides as Therapeutic Agents in the Treatment of Disease In force · Medium confidence | Drexel University | In force | Medium confidence | |
| US 10,337,015 | Modulation of Pre-Mrna Using Splice Modulating Oligonucleotides as Therapeutic Agents in the Treatment of Disease In force · Medium confidence | Drexel University | In force | Medium confidence | |
| US 9,871,284 | Systems and Methods for Selecting Reconfigurable Antennas in MIMO Systems In force · High confidence | Drexel University | In force | High confidence | |
| US 8,680,254 | Modulation of Pre-Mrna Using Splice Modulating Oligonucleotides as Therapeutic Agents in the Treatment of Disease In force · High confidence | Drexel University | In force | High confidence | |
| US 8,015,125 | Multi-Scale Segmentation and Partial Matching 3D Models In force · High confidence | Drexel University | In force | High confidence | |
| US 9,599,612 | Flow-Based Enhancement of Specificity for Label-Free Biochemical Assays In force · High confidence | Drexel University | In force | High confidence | |
| US 8,906,659 | Plasma Treatment for Growth Factor Release from Cells and Tissues In force · High confidence | Drexel University | In force | High confidence | |
| 10 more term ends in 2030 · Pro | |||||
10 of 20 patents shown. Soonest term end first, then patent number.
Pro members see all 20.
18 of these are in force and held by Drexel University.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.